Immunology Program
The Jayanta Chaudhuri Lab
Research
Featured News
Publications Highlights
Sharma, R., Smolkin, R. M., Chowdhury, P., Fernandez, K. C., Kim, Y., Cols, M., Alread, W., Yen, W.-F., Hu, W., Wang, Z.-M., Violante, S., Chaligné, R., Li, M. O., Cross, J. R., & Chaudhuri, J. (2023). Distinct metabolic requirements regulate B cell activation and germinal center responses. Nature Immunology, 24(8), 1358–1369. https://doi.org/10.1038/s41590-023-01540-y
Fernandez, K. C., Feeney, L., Smolkin, R. M., Yen, W.-F., Matthews, A. J., Alread, W., Petrini, J. H. J., & Chaudhuri, J. (2022). The structure-selective endonucleases GEN1 and MUS81 mediate complementary functions in safeguarding the genome of proliferating B lymphocytes. eLife, 11, e77073. https://doi.org/10.7554/eLife.77073
Maekawa, K., Yamada, S., Sharma, R., Chaudhuri, J., & Keeney, S. (2022). Triple-helix potential of the mouse genome. Proceedings of the National Academy of Sciences of the United States of America, 119(19), e2203967119. https://doi.org/10.1073/pnas.2203967119
Yewdell, W. T., Smolkin, R. M., Belcheva, K. T., Mendoza, A., Michaels, A. J., Cols, M., Angeletti, D., Yewdell, J. W., & Chaudhuri, J. (2021). Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection. Cell Reports, 37(6), 109961. https://doi.org/10.1016/j.celrep.2021.109961
Mendoza, A., Yewdell, W. T., Hoyos, B., Schizas, M., Bou-Puerto, R., Michaels, A. J., Brown, C. C., Chaudhuri, J., & Rudensky, A. Y. (2021). Assembly of a spatial circuit of T-bet-expressing T and B lymphocytes is required for antiviral humoral immunity. Science Immunology, 6(60), eabi4710. https://doi.org/10.1126/sciimmunol.abi4710
People
Jayanta Chaudhuri, PhD
- Immunologist Jayanta Chaudhuri studies the mechanisms of immunoglobulin gene diversification.
- PhD, Albert Einstein College of Medicine
- [email protected]
- Email Address
- 646-888-2357
- Office Phone
Members
- PhD, Albert Einstein College of Medicine
- MD, University of Pittsburgh School of Medicine
- MD, New York School of Medicine
- PhD, International Agency for Research on Cancer – World Health Organization (IARC-WHO)
- 646-888-2344
- Lab Phone
- PhD, University of Murcia
- PhD, University of Lausanne
- 646-888-2344
- Lab Phone
- BBMedSci, University of Malaya
- 646-888-2614
- Lab Phone
- BS, University of California, Los Angeles
- 646-888-2344
- Lab Phone
- MS, The University of Nottingham
- 646-888-2344
- Lab Phone
- BS, The City College of New York
- 646-888-2614
- Lab Phone
- BS, Pohang University of Science and Technology
- 646-888-2344
- Lab Phone
- BS, The George Washington University
- 646-888-2614
- Lab Phone
- PhD, Jawaharlal Nehru University
- BS-MS, Indian Institute of Science Education & Research, Kolkata
- BS, Hunter College
- MD, St. George's University School of Medicine
- MD, State University of New York at Buffalo
- MS, McGill University
Lab Alumni
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs
Get in Touch
-
Lab Head Email
-
Office Phone
-
Office Fax
-
Lab Phone
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jayanta Chaudhuri discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].